Claudia Crocini
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocytes, Cardiac | 14 | 2022 | 449 | 2.950 |
Why?
| Cardiomyopathy, Hypertrophic | 5 | 2022 | 121 | 1.270 |
Why?
| Optogenetics | 3 | 2018 | 95 | 1.160 |
Why?
| Action Potentials | 8 | 2018 | 406 | 1.040 |
Why?
| Myocardial Contraction | 6 | 2017 | 313 | 1.030 |
Why?
| Heart | 4 | 2020 | 612 | 1.000 |
Why?
| Calcium Signaling | 6 | 2017 | 217 | 0.860 |
Why?
| Heart Failure | 4 | 2023 | 1945 | 0.770 |
Why?
| Sarcolemma | 4 | 2018 | 29 | 0.620 |
Why?
| Arrhythmias, Cardiac | 3 | 2018 | 279 | 0.620 |
Why?
| Mechanical Phenomena | 1 | 2019 | 80 | 0.610 |
Why?
| Excitation Contraction Coupling | 4 | 2017 | 17 | 0.610 |
Why?
| Channelrhodopsins | 1 | 2016 | 18 | 0.540 |
Why?
| Electric Countershock | 1 | 2016 | 104 | 0.520 |
Why?
| Adrenergic beta-Agonists | 1 | 2016 | 126 | 0.510 |
Why?
| Myofibrils | 1 | 2015 | 46 | 0.510 |
Why?
| Biocompatible Materials | 1 | 2019 | 369 | 0.500 |
Why?
| Calcium | 3 | 2017 | 1108 | 0.490 |
Why?
| Light | 1 | 2017 | 336 | 0.470 |
Why?
| Muscle Cells | 1 | 2014 | 42 | 0.470 |
Why?
| Muscle Proteins | 2 | 2013 | 210 | 0.460 |
Why?
| Heart Diseases | 2 | 2017 | 331 | 0.450 |
Why?
| Hydrogels | 1 | 2019 | 573 | 0.410 |
Why?
| Heart Ventricles | 4 | 2018 | 712 | 0.380 |
Why?
| Cardiomyopathy, Dilated | 3 | 2022 | 348 | 0.380 |
Why?
| Animals | 21 | 2023 | 31698 | 0.360 |
Why?
| Repressor Proteins | 1 | 2013 | 366 | 0.340 |
Why?
| Mutation | 6 | 2022 | 3345 | 0.330 |
Why?
| Cardiomyopathies | 2 | 2023 | 298 | 0.320 |
Why?
| Tissue Engineering | 1 | 2013 | 364 | 0.320 |
Why?
| Nuclear Proteins | 1 | 2013 | 591 | 0.310 |
Why?
| Heart Atria | 2 | 2020 | 107 | 0.310 |
Why?
| Intracellular Space | 2 | 2019 | 68 | 0.300 |
Why?
| Rats | 5 | 2020 | 4958 | 0.250 |
Why?
| Cells, Cultured | 5 | 2017 | 3885 | 0.250 |
Why?
| Rats, Wistar | 2 | 2016 | 368 | 0.240 |
Why?
| Myocardium | 5 | 2023 | 913 | 0.230 |
Why?
| Hypertrophy, Left Ventricular | 2 | 2022 | 102 | 0.220 |
Why?
| Mice | 9 | 2022 | 14863 | 0.210 |
Why?
| Green Fluorescent Proteins | 2 | 2014 | 371 | 0.200 |
Why?
| Phenotype | 4 | 2019 | 2796 | 0.190 |
Why?
| Disease Models, Animal | 5 | 2020 | 3532 | 0.190 |
Why?
| Rats, Inbred SHR | 1 | 2020 | 41 | 0.180 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2021 | 88 | 0.180 |
Why?
| Capillaries | 1 | 2020 | 91 | 0.170 |
Why?
| Dilatation | 1 | 2020 | 60 | 0.170 |
Why?
| Capsules | 1 | 2019 | 36 | 0.160 |
Why?
| Optical Imaging | 2 | 2018 | 54 | 0.160 |
Why?
| Troponin T | 2 | 2017 | 49 | 0.160 |
Why?
| Cellular Microenvironment | 1 | 2019 | 78 | 0.160 |
Why?
| Sarcoplasmic Reticulum | 2 | 2017 | 43 | 0.150 |
Why?
| Coronary Vessels | 1 | 2020 | 227 | 0.150 |
Why?
| Myosin Heavy Chains | 1 | 2019 | 177 | 0.150 |
Why?
| Microscopy, Confocal | 2 | 2017 | 304 | 0.150 |
Why?
| Atrioventricular Block | 1 | 2018 | 37 | 0.150 |
Why?
| Electric Stimulation Therapy | 1 | 2018 | 56 | 0.150 |
Why?
| Protein Transport | 1 | 2019 | 395 | 0.150 |
Why?
| Cell Surface Extensions | 1 | 2017 | 11 | 0.140 |
Why?
| Sex Characteristics | 1 | 2022 | 640 | 0.140 |
Why?
| Ranolazine | 1 | 2017 | 22 | 0.140 |
Why?
| Sodium Channel Blockers | 1 | 2017 | 23 | 0.140 |
Why?
| Heart Conduction System | 1 | 2017 | 80 | 0.140 |
Why?
| Extracellular Space | 1 | 2017 | 116 | 0.140 |
Why?
| Fibroblasts | 1 | 2021 | 838 | 0.130 |
Why?
| Sodium | 1 | 2017 | 183 | 0.130 |
Why?
| Atrial Fibrillation | 1 | 2020 | 322 | 0.130 |
Why?
| Cell Survival | 1 | 2019 | 1021 | 0.130 |
Why?
| Ion Transport | 1 | 2015 | 55 | 0.130 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2013 | 133 | 0.130 |
Why?
| Receptors, Adrenergic, beta | 1 | 2016 | 127 | 0.130 |
Why?
| Actin Cytoskeleton | 1 | 2015 | 93 | 0.120 |
Why?
| Equipment Design | 1 | 2016 | 508 | 0.120 |
Why?
| Humans | 12 | 2023 | 114662 | 0.120 |
Why?
| Polyethylene Glycols | 1 | 2019 | 561 | 0.120 |
Why?
| Proteasome Inhibitors | 1 | 2013 | 40 | 0.110 |
Why?
| Lamin Type A | 1 | 2013 | 40 | 0.110 |
Why?
| Haploinsufficiency | 1 | 2013 | 42 | 0.110 |
Why?
| Dependovirus | 1 | 2013 | 52 | 0.100 |
Why?
| Transduction, Genetic | 1 | 2013 | 113 | 0.100 |
Why?
| LIM Domain Proteins | 1 | 2012 | 13 | 0.100 |
Why?
| Heterozygote | 1 | 2013 | 251 | 0.100 |
Why?
| Fluorescent Antibody Technique | 1 | 2013 | 397 | 0.100 |
Why?
| Mice, Transgenic | 4 | 2019 | 1947 | 0.100 |
Why?
| Cell Proliferation | 1 | 2019 | 2186 | 0.100 |
Why?
| Genetic Vectors | 1 | 2013 | 289 | 0.100 |
Why?
| Oligopeptides | 1 | 2013 | 236 | 0.090 |
Why?
| Transfection | 1 | 2013 | 866 | 0.090 |
Why?
| Animals, Newborn | 1 | 2013 | 778 | 0.090 |
Why?
| Gene Expression | 1 | 2015 | 1421 | 0.090 |
Why?
| Male | 9 | 2022 | 55583 | 0.090 |
Why?
| Models, Biological | 1 | 2017 | 1620 | 0.090 |
Why?
| Mice, Knockout | 1 | 2015 | 2568 | 0.080 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 386 | 0.080 |
Why?
| Rats, Inbred WKY | 2 | 2020 | 32 | 0.080 |
Why?
| Genotype | 1 | 2013 | 1760 | 0.070 |
Why?
| Mice, Inbred C57BL | 4 | 2019 | 4692 | 0.070 |
Why?
| Aging | 1 | 2017 | 1618 | 0.070 |
Why?
| Time Factors | 2 | 2017 | 6114 | 0.070 |
Why?
| Gene Expression Regulation | 1 | 2013 | 2319 | 0.060 |
Why?
| Isoproterenol | 1 | 2022 | 106 | 0.050 |
Why?
| Sarcomeres | 1 | 2022 | 90 | 0.050 |
Why?
| Myosins | 1 | 2022 | 126 | 0.050 |
Why?
| Angiotensin II | 1 | 2022 | 87 | 0.050 |
Why?
| Alternative Splicing | 1 | 2023 | 187 | 0.050 |
Why?
| Electrophysiological Phenomena | 1 | 2020 | 48 | 0.040 |
Why?
| Myofibroblasts | 1 | 2021 | 116 | 0.040 |
Why?
| Vascular Remodeling | 1 | 2020 | 153 | 0.040 |
Why?
| Swine | 1 | 2021 | 700 | 0.040 |
Why?
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 70 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2020 | 316 | 0.040 |
Why?
| Extracellular Matrix | 1 | 2021 | 436 | 0.040 |
Why?
| Fluorescence Recovery After Photobleaching | 1 | 2017 | 18 | 0.040 |
Why?
| Proteomics | 1 | 2023 | 836 | 0.040 |
Why?
| Imaging, Three-Dimensional | 1 | 2020 | 511 | 0.030 |
Why?
| Sex Factors | 1 | 2022 | 1715 | 0.030 |
Why?
| Echocardiography, Doppler | 1 | 2017 | 92 | 0.030 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2017 | 172 | 0.030 |
Why?
| Membrane Potentials | 1 | 2017 | 248 | 0.030 |
Why?
| Hemodynamics | 1 | 2020 | 1012 | 0.030 |
Why?
| Blotting, Western | 1 | 2017 | 1147 | 0.030 |
Why?
| Cell Differentiation | 1 | 2021 | 1700 | 0.030 |
Why?
| Ventricular Function, Left | 1 | 2017 | 467 | 0.030 |
Why?
| Ventricular Dysfunction, Left | 1 | 2017 | 358 | 0.030 |
Why?
| Models, Theoretical | 1 | 2017 | 515 | 0.030 |
Why?
| Heart Rate | 1 | 2017 | 709 | 0.030 |
Why?
| Ubiquitin | 1 | 2013 | 57 | 0.030 |
Why?
| Proteolysis | 1 | 2013 | 142 | 0.030 |
Why?
| Models, Cardiovascular | 1 | 2013 | 178 | 0.020 |
Why?
| Pedigree | 1 | 2012 | 460 | 0.020 |
Why?
| Cell Nucleus | 1 | 2013 | 554 | 0.020 |
Why?
| Signal Transduction | 1 | 2022 | 4512 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2017 | 2085 | 0.020 |
Why?
| Female | 3 | 2022 | 59493 | 0.020 |
Why?
| Disease Progression | 1 | 2013 | 2380 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2017 | 3046 | 0.020 |
Why?
| Case-Control Studies | 1 | 2012 | 3003 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2013 | 1472 | 0.010 |
Why?
| Young Adult | 1 | 2012 | 10466 | 0.010 |
Why?
| Aged | 1 | 2012 | 19069 | 0.010 |
Why?
| Adolescent | 1 | 2012 | 17841 | 0.010 |
Why?
| Child | 1 | 2012 | 18412 | 0.010 |
Why?
| Middle Aged | 1 | 2012 | 26733 | 0.010 |
Why?
| Adult | 1 | 2012 | 30544 | 0.010 |
Why?
|
|
Crocini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|